399 related articles for article (PubMed ID: 8289341)
21. Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59.
Rho J; Lee S; de Villiers EM; Choe J
Virus Res; 1997 Feb; 47(2):155-66. PubMed ID: 9085547
[TBL] [Abstract][Full Text] [Related]
22. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
23. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
[TBL] [Abstract][Full Text] [Related]
24. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.
Hou SY; Wu SY; Zhou T; Thomas MC; Chiang CM
Mol Cell Biol; 2000 Jan; 20(1):113-25. PubMed ID: 10594014
[TBL] [Abstract][Full Text] [Related]
25. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
[TBL] [Abstract][Full Text] [Related]
26. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region.
Jackson ME; Campo MS
J Virol; 1995 Oct; 69(10):6038-46. PubMed ID: 7666508
[TBL] [Abstract][Full Text] [Related]
27. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
28. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
Stubenrauch F; Leigh IM; Pfister H
J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
[TBL] [Abstract][Full Text] [Related]
29. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
30. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
Steger G; Corbach S
J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
32. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
33. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
Hou SY; Wu SY; Chiang CM
J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
[TBL] [Abstract][Full Text] [Related]
35. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
36. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Oh ST; Kyo S; Laimins LA
J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
38. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
Vance KW; Campo MS; Morgan IM
J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
[TBL] [Abstract][Full Text] [Related]
39. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter.
Apt D; Watts RM; Suske G; Bernard HU
Virology; 1996 Oct; 224(1):281-91. PubMed ID: 8862423
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16.
Desaintes C; Hallez S; Van Alphen P; Burny A
J Virol; 1992 Jan; 66(1):325-33. PubMed ID: 1309249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
